Tech Company Financing Transactions

Atox Bio Funding Round

Private investors participated in a $33 million funding round for Atox Bio. The round was announced by the company on 5/1/2019.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds purposes were not disclosed. 15 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Mailing Address
55 Vilcom Ctr. Dr. 230
Chapel Hill, NC 27514
Email Address
Not Recorded
Atox Bio is a clinical stage biotechnology company that develops therapeutics for diseases mediated by a deregulated inflammatory response.
Atox Bio LinkedIn Company Profile
Social Media
Atox Bio Company Twitter Account
Company News
Atox Bio News
Atox Bio on Facebook
Atox Bio on YouTube

Management Team

Email & Social
Chief Executive Officer
Daniel Teleman
  Daniel Teleman LinkedIn Profile  Daniel Teleman Twitter Account  Daniel Teleman News  Daniel Teleman on Facebook
Chief Financial Officer
Esti Hayun
  Esti Hayun LinkedIn Profile  Esti Hayun Twitter Account  Esti Hayun News  Esti Hayun on Facebook
Chief Medical Officer
Wayne Dankner
  Wayne Dankner LinkedIn Profile  Wayne Dankner Twitter Account  Wayne Dankner News  Wayne Dankner on Facebook
Chief Scientific Officer
Raymond Kaempfer
  Raymond Kaempfer LinkedIn Profile  Raymond Kaempfer Twitter Account  Raymond Kaempfer News  Raymond Kaempfer on Facebook
Vice President
Corinne Zollmann
  Corinne Zollmann LinkedIn Profile  Corinne Zollmann Twitter Account  Corinne Zollmann News  Corinne Zollmann on Facebook
VP - Bus. Development
Robert Greif
  Robert Greif LinkedIn Profile  Robert Greif Twitter Account  Robert Greif News  Robert Greif on Facebook
VP - R & D
Anat Shirvan
  Anat Shirvan LinkedIn Profile  Anat Shirvan Twitter Account  Anat Shirvan News  Anat Shirvan on Facebook
VP - Regulatory Affairs
Meir Batito
  Meir Batito LinkedIn Profile  Meir Batito Twitter Account  Meir Batito News  Meir Batito on Facebook



Browse more venture capital transactions:

Prev: 5/1/2019: Allganize venture capital transaction
Next: 5/1/2019: Duco Advisors venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary